Comparison of capillary blood and plasma samples for the evaluation of seroprevalence to SARS-CoV-2 antibodies by lateral flow immunoassay in a university population in Medellín, Colombia, 2020
Open Access
- 15 December 2022
- journal article
- research article
- Published by Elsevier in Public Health in Practice
- Vol. 5, 100347
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- COVID-19 testing: One size does not fit allScience, 2021
- A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severityNature Communications, 2020
- Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2Annals of Internal Medicine, 2020
- Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detectionJournal of Clinical Virology, 2020
- Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosisJournal of Clinical Virology, 2020
- Test performance evaluation of SARS-CoV-2 serological assaysmedRxiv, 2020
- The Appropriate Use of Testing for COVID-19Western Journal of Emergency Medicine, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Sensitivity of the Wondfo One Step COVID-19 test using serum samplesClinics, 2020